Inovio Pharmaceuticals Inc (INO)
Healthcare
Biotechnology
0.70 $
+2.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Inovio Pharmaceuticals Inc (INO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32 | -29 | -26 | -29 | -28 | -84 | -20 | -27 | -21 | -22 | -19 | -22 | -83 | |
| 1.1 | 1.0 | 0.2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 3.0 | |
| 2.9 | 2.1 | 2.3 | 2.5 | 1.5 | 5.3 | 1.3 | 1.4 | 0.8 | 0.8 | 0.8 | 0.7 | 3.1 | |
| 6.3 | 11 | – | – | – | – | – | – | – | – | – | – | – | |
| -2.2 | -7.4 | -2.1 | -0.9 | 1.8 | -2.9 | -0.7 | -4.8 | 0.1 | -0.7 | -3.8 | -1.5 | -6.0 | |
| 0.0 | 0.0 | 0.3 | 0.0 | 0.5 | 0.5 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 | |
| 54 | -5.5 | 20 | 45 | 10.0 | 69,371 | 35 | -0.1 | 5.3 | 8.9 | -0.1 | 2.6 | 17 | |
| 0.0 | – | 0.5 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| 2.9 | 0.7 | 1.8 | -11 | 33 | 0.7 | 29 | 1.0 | 0.0 | 25 | 27 | 1.0 | 53 | |
| 24 | -34 | -4.5 | 5.3 | 15 | -13 | 44 | -26 | -16 | 12 | 7.7 | -18 | -14 | |
| -32 | -29 | -26 | -29 | -29 | -84 | -20 | -27 | -21 | -22 | -19 | -22 | -84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.